271 related articles for article (PubMed ID: 15458436)
21. Renovascular hypertension does not influence repair of glomerular lesions induced by anti-thymocyte glomerulonephritis.
Wenzel UO; Wolf G; Thaiss F; Helmchen U; Stahl RA
Kidney Int; 2000 Sep; 58(3):1135-47. PubMed ID: 10972677
[TBL] [Abstract][Full Text] [Related]
22. FTY720-induced lymphocyte homing modulates post-transplant preservation/reperfusion injury.
Dragun D; Böhler T; Nieminen-Kelhä M; Waiser J; Schneider W; Haller H; Luft FC; Budde K; Neumayer HH
Kidney Int; 2004 Mar; 65(3):1076-83. PubMed ID: 14871428
[TBL] [Abstract][Full Text] [Related]
23. Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis.
Nakamura T; Obata J; Kimura H; Ohno S; Yoshida Y; Kawachi H; Shimizu F
Kidney Int; 1999 Mar; 55(3):877-89. PubMed ID: 10027924
[TBL] [Abstract][Full Text] [Related]
24. FTY720 inhibits tubulointerstitial inflammation in albumin overload-induced nephropathy of rats via the Sphk1 pathway.
Xu M; Liu D; Ding LH; Ma KL; Wu M; Lv LL; Wen Y; Liu H; Tang RN; Liu BC
Acta Pharmacol Sin; 2014 Dec; 35(12):1537-45. PubMed ID: 25399649
[TBL] [Abstract][Full Text] [Related]
25. NO mediates antifibrotic actions of L-arginine supplementation following induction of anti-thy1 glomerulonephritis.
Peters H; Daig U; Martini S; Rückert M; Schäper F; Liefeldt L; Krämer S; Neumayer HH
Kidney Int; 2003 Aug; 64(2):509-18. PubMed ID: 12846746
[TBL] [Abstract][Full Text] [Related]
26. Treatment with the immunomodulator FTY720 (fingolimod) significantly reduces renal inflammation in murine unilateral ureteral obstruction.
Thangada S; Shapiro LH; Silva C; Yamase H; Hla T; Ferrer FA
J Urol; 2014 May; 191(5 Suppl):1508-16. PubMed ID: 24679864
[TBL] [Abstract][Full Text] [Related]
27. Benidipine, a long-acting calcium-channel blocker, prevents the progression to end-stage renal failure in a rat mesangioproliferative glomerulonephritis.
Nakamura T; Obata JE; Onitsuka M; Shimada Y; Yoshida Y; Kawachi H; Shimizu F
Nephron; 2000 Nov; 86(3):315-26. PubMed ID: 11096289
[TBL] [Abstract][Full Text] [Related]
28. Tacrolimus in combination with FTY720--an analysis of renal and blood parameters.
Gallo AP; Silva LB; Franco M; Burdmann EA; Bueno V
Int Immunopharmacol; 2006 Dec; 6(13-14):1919-24. PubMed ID: 17219691
[TBL] [Abstract][Full Text] [Related]
29. Effects of immunosuppressant FTY720 on renal and hepatic hemodynamics in the rat.
Tawadrous MN; Mabuchi A; Zimmermann A; Wheatley AM
Transplantation; 2002 Sep; 74(5):602-10. PubMed ID: 12352874
[TBL] [Abstract][Full Text] [Related]
30. Reduction of CD4 positive T cells and improvement of pathological changes of collagen-induced arthritis by FTY720.
Wang F; Tan W; Guo D; He S
Eur J Pharmacol; 2007 Nov; 573(1-3):230-40. PubMed ID: 17716652
[TBL] [Abstract][Full Text] [Related]
31. Monoclonal antibody 1-22-3-induced glomerulonephritis in uninephrectomized rats as a model of progressive renal failure.
Tomita M; Sogabe H; Nakazato S; Nakatsuji S; Noto T; Hamada K; Kawachi H; Shimizu F; Matsuo M; Mutoh S
Nephrol Dial Transplant; 2005 Nov; 20(11):2358-67. PubMed ID: 16091375
[TBL] [Abstract][Full Text] [Related]
32. t-PA promotes glomerular plasmin generation and matrix degradation in experimental glomerulonephritis.
Haraguchi M; Border WA; Huang Y; Noble NA
Kidney Int; 2001 Jun; 59(6):2146-55. PubMed ID: 11380816
[TBL] [Abstract][Full Text] [Related]
33. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing.
Chiba K; Yanagawa Y; Masubuchi Y; Kataoka H; Kawaguchi T; Ohtsuki M; Hoshino Y
J Immunol; 1998 May; 160(10):5037-44. PubMed ID: 9590253
[TBL] [Abstract][Full Text] [Related]
34. Rapamycin attenuates the severity of murine adriamycin nephropathy.
Lui SL; Tsang R; Chan KW; Zhang F; Tam S; Yung S; Chan TM
Am J Nephrol; 2009; 29(4):342-52. PubMed ID: 18948688
[TBL] [Abstract][Full Text] [Related]
35. CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome.
Vielhauer V; Berning E; Eis V; Kretzler M; Segerer S; Strutz F; Horuk R; Gröne HJ; Schlöndorff D; Anders HJ
Kidney Int; 2004 Dec; 66(6):2264-78. PubMed ID: 15569315
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-2-dependent mechanisms are involved in the development of glomerulosclerosis after partial renal ablation in rats.
Hamar P; Peti-Peterdi J; Szabó A; Becker G; Flach R; Rosivall L; Heemann U
Exp Nephrol; 2001; 9(2):133-41. PubMed ID: 11150862
[TBL] [Abstract][Full Text] [Related]
37. FTY720 ameliorates experimental autoimmune neuritis by inhibition of lymphocyte and monocyte infiltration into peripheral nerves.
Zhang Z; Zhang ZY; Fauser U; Schluesener HJ
Exp Neurol; 2008 Apr; 210(2):681-90. PubMed ID: 18261728
[TBL] [Abstract][Full Text] [Related]
38. FTY720 ameliorates murine sclerodermatous chronic graft-versus-host disease by promoting expansion of splenic regulatory cells and inhibiting immune cell infiltration into skin.
Huu DL; Matsushita T; Jin G; Hamaguchi Y; Hasegawa M; Takehara K; Fujimoto M
Arthritis Rheum; 2013 Jun; 65(6):1624-35. PubMed ID: 23508350
[TBL] [Abstract][Full Text] [Related]
39. [Effects of Shensu II Recipe on the expressions of transforming growth factor-beta1, and plasminogen activator inhibitor-1 in the focal segmental glomerulosclerosis rats].
Dou YT; Yang HT; Cao SL
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Nov; 31(11):1531-7. PubMed ID: 22303720
[TBL] [Abstract][Full Text] [Related]
40. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
Zoja C; Corna D; Bruzzi I; Foglieni C; Bertani T; Remuzzi G; Benigni A
Exp Nephrol; 1996; 4(4):213-21. PubMed ID: 8983642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
